Comparison of effects of inhibitors of viral and cellular protein kinases on human cytomegalovirus disruption of nuclear lamina and nuclear egress

Journal of Virology

Volumn 88, Issue 18, 2014, Pages 10982-10985

  Sharma, Mayuri ^a   Coen, Donald M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAVIR; BISINDOLYLMALEIMIDE 1; CYCLIN DEPENDENT KINASE 1; DIMETHYL SULFOXIDE; DNA POLYMERASE; HUMAN CYTOMEGALOVIRUS KINASE UL97; PP28 PROTEIN; PROTEIN KINASE C; ROSCOVITINE; UNCLASSIFIED DRUG; VIRAL DNA POLYMERASE UL44; VIRAL DNA POLYMERASE UL50; VIRUS ENZYME; VIRUS PROTEIN; GANCICLOVIR KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE INHIBITOR;

ARTICLE; AUTOPHOSPHORYLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN CYTOMEGALOVIRUS; MEMBRANE DAMAGE; NONHUMAN; NUCLEAR LAMINA; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRAL NUCLEAR EGRESS; VIRAL PHENOMENA AND FUNCTIONS; VIRUS CAPSID; VIRUS LOAD; VIRUS MORPHOLOGY; VIRUS NUCLEOCAPSID; VIRUS STRAIN; ANTAGONISTS AND INHIBITORS; CELL LINE; CELL NUCLEUS; COMPARATIVE STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS ASSEMBLY; VIRUS RELEASE;

CAPSID; CELL LINE; CELL NUCLEUS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; NUCLEAR LAMINA; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; VIRUS ASSEMBLY; VIRUS RELEASE;

EID: 84906350501     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01391-14     Document Type: Article

References (25)

1. Mettenleiter TC, Klupp BG, Granzow H. 2006. Herpesvirus assembly: a tale of two membranes. Curr. Opin. Microbiol. 9:423-429. http://dx.doi.org/10.1016/j.mib.2006.06.013.
2. Mettenleiter TC and Minson T. 2006. Egress of alphaherpesviruses. J. Virol. 80:1610-1612. http://dx.doi.org/10.1128/JVI.80.3.1610-1612.2006.
3. Mettenleiter TC. 2002. Herpesvirus assembly and egress. J. Virol. 76: 1537-1547. http://dx.doi.org/10.1128/JVI.76.4.1537-1547.2002.
4. Park R, Baines JD. 2006. Herpes simplex virus type 1 infection induces activation and recruitment of protein kinase C to the nuclear membrane and increased phosphorylation of lamin B. J. Virol. 80:494-504. http://dx.doi.org/10.1128/JVI.80.1.494-504.2006.
5. Muranyi W, Haas J, Wagner M, Krohne G, Koszinowski UH. 2002. Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science 297:854-857. http://dx.doi.org/10.1126/science.1071506.
6. Leach NR, Roller RJ. 2010. Significance of host cell kinases in herpes simplex virus type 1 egress and lamin-associated protein disassembly from the nuclear lamina. Virology 406:127-137. http://dx.doi.org/10.1016/j.virol.2010.07.002.
7. Speese SD, Ashley J, Jokhi V, Nunnari J, Barria R, Li Y, Ataman B, Koon A, Chang YT, Li Q, Moore MJ, Budnik V. 2012. Nuclear envelope budding enables large ribonucleoprotein particle export during synaptic Wnt signaling. Cell 149:832-846. http://dx.doi.org/10.1016/j.cell.2012.03.032.
8. Sharma M, Kamil JP, Coughlin M, Reim NI, Coen DM. 2014. Human cytomegalovirus UL50 and UL53 recruit viral protein kinase UL97, not protein kinase C, for disruption of nuclear lamina and nuclear egress in infected cells. J. Virol. 88:249 -262. http://dx.doi.org/10.1128/JVI.02358-13.
9. Hamirally S, Kamil JP, Ndassa-Colday YM, Lin AJ, Jahng WJ, Baek MC, Noton S, Silva LA, Simpson-Holley M, Knipe DM, Golan DE, Marto JA, Coen DM. 2009. Viral mimicry of Cdc2/cyclin-dependent kinase 1 mediates disruption of nuclear lamina during human cytomegalovirus nuclear egress. PLoS Pathog. 5(1):e1000275. http://dx.doi.org/10.1371/journal.ppat.1000275.
10. Krosky PM, Baek MC, Coen DM. 2003. The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J. Virol. 77:905-914. http://dx.doi.org/10.1128/JVI.77.2.905-914.2003.
11. Reim NI, Kamil JP, Wang D, Lin A, Sharma M, Ericsson M, Pesola JM, Golan DE, Coen DM. 2013. Inactivation of retinoblastoma protein does not overcome the requirement for human cytomegalovirus UL97 in lamina disruption and nuclear egress. J. Virol. 87:5019-5027. http://dx.doi.org/10.1128/JVI.00007-13.
12. Mocarski ES, Shenk JT, Griffith P, Pass RF. 2013. Cytomegaloviruses, p 1960-2014. In Knipe DM, Howley PM (ed), Fields virology, 6th ed, vol 1. Lippincott Williams & Wilkins, Philadelphia, PA.
13. Kamil JP, Hume AJ, Jurak I, Munger K, Kalejta RF, Coen DM. 2009. Human papillomavirus 16 E7 inactivator of retinoblastoma family proteins complements human cytomegalovirus lacking UL97 protein kinase. Proc. Natl. Acad. Sci. U. S. A. 106:16823-16828. http://dx.doi.org/10.1073 /pnas.0901521106.
14. Williams SL, Hartline CB, Kushner NL, Harden EA, Bidanset DJ, Drach JC, Townsend LB, Underwood MR, Biron KK, Kern ER. 2003. In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses. Antimicrob. Agents Chemother. 47:2186-2192. http://dx.doi.org /10.1128/AAC.47.7.2186-2192.2003.
15. Sanchez V, McElroy AK, Yen J, Tamrakar S, Clark CL, Schwartz RA, Spector DH. 2004. Cyclin-dependent kinase activity is required at early times for accurate processing and accumulation of the human cytomegalovirus UL122-123 and UL37 immediate-early transcripts and at later times for virus production. J. Virol. 78:11219-11232. http://dx.doi.org/10.1128/JVI.78.20.11219-11232.2004.
16. Biron KK, Harvey RJ, Chamberlain SC, Good SS, Smith AA, III, Davis MG, Talarico CL, Miller WH, Ferris R, Dornsife RE, Stanat SC, Drach JC, Townsend LB, Koszalka GW. 2002. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. Antimicrob. Agents Chemother. 46: 2365-2372. http://dx.doi.org/10.1128/AAC.46.8.2365-2372.2002.
17. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J. 1991. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:15771-15781.
18. Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP. 1997. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243:527-536. http://dx.doi.org/10.1111/j.1432-1033.1997.t01-2-00527.x.
19. Buser C, Walther P, Mertens T, Michel D. 2007. Cytomegalovirus primary envelopment occurs at large infoldings of the inner nuclear membrane. J. Virol. 81:3042-3048. http://dx.doi.org/10.1128/JVI.01564-06.
20. Camozzi D, Pignatelli S, Valvo C, Lattanzi G, Capanni C, Dal Monte P, Landini MP. 2008. Remodelling of the nuclear lamina during human cytomegalovirus infection: role of the viral proteins pUL50 and pUL53. J. Gen. Virol. 89:731-740. http://dx.doi.org/10.1099/vir.0.83377-0.
21. Sanchez V, McElroy AK, Spector DH. 2003. Mechanisms governing maintenance of Cdk1/cyclin B1 kinase activity in cells infected with human cytomegalovirus. J. Virol. 77:13214-13224. http://dx.doi.org/10.1128/JVI.77.24.13214-13224.2003.
22. Sanchez V, Spector DH. 2006. Cyclin-dependent kinase activity is required for efficient expression and posttranslational modification of human cytomegalovirus proteins and for production of extracellular particles. J. Virol. 80:5886-5896. http://dx.doi.org/10.1128/JVI.02656-05.
23. Gibson W. 1996. Structure and assembly of the virion. Intervirology 39: 350-354.
24. Collas P, Thompson L, Fields AP, Poccia DL, Courvalin JC. 1997. Protein kinase C-mediated interphase lamin B phosphorylation and solubilization. J. Biol. Chem. 272:21274-21280. http://dx.doi.org/10.1074 /jbc.272.34.21274.
25. Hocevar BA, Burns DJ, Fields AP. 1993. Identification of protein kinase C (PKC) phosphorylation sites on human lamin B. Potential role of PKC in nuclear lamina structural dynamics. J. Biol. Chem. 268:7545-7552.